Skip to main content
. 2022 Sep 26;13:5654. doi: 10.1038/s41467-022-32867-z

Fig. 3. Anti SARS-CoV-2 IgG Fc core fucosylation in critical and severe COVID-19 cases.

Fig. 3

IgG-Fc core fucosylation levels of SARS-CoV-2–specific IgG in critically (red bars), severely (blue bars) and mildly (grey bars) diseased COVID-19 patients. Analysis was carried out on a pool of 5 different sera. Measured OD values (fucosylation) of the generated eluates were normalized to their respective IgG concentrations determined by antigen-specific S1 and N ELISA. a S-IgG-Fc-fucosylation and b N-IgG-Fc-fucosylation in critically and severely diseased patients characterized by either high (red) or low (patterned) CD16A-activation levels in the FcγRIIIA/CD16A reporter assay. Of note, for mildly diseased patients only sera displaying low CD16 activation levels were available and analyzed respectively. The mean and standard deviation (SD) of three independent experiments is depicted. Each dot represents one individual experiment. Statistical tests using a two-factorial linear model (one-sided, no adjustments) indicate three significant differences between the low and high categories as well as between patients of the different groups (***p < 0.001, **p < 0.01, *p < 0.05). n.a.: not available. Source data are provided as a Source Data file.